Precision delivers end-to-end, biomarker-driven clinical trial execution: Rapid study startup, integrated biomarker strategies, and full service, complex global clinical trials—all to accelerate the path to market for emerging and mid-stage biopharma in the US, EU, and APAC. What makes Precision unique are the scientists, clinicians, and operational experts dedicated to biomarker-driven clinical development.
How Precision Supports You
The convenience of centralized services: We manage every aspect of your clinical trials under a single roof: strategy and design, and full clinical trial execution globally.
The power of complex biomarker assays and informatics: Using both clinical and translational data, we optimize development and shorten the R&D curve. Our experts continually look ahead to the next step in the development pathway, ensuring that data collection and analysis promote future developmental success.
The advantage of truly global reach: Our 2,000-person team across 34 offices delivers biomarker-driven trials—from design to sample logistics to full scale trial execution around the globe—supporting you wherever your trial may be.